Gavo-cel

TC-210 · TCR2 Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gavo-cel, covering 2025-08-27 to 2025-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]